New psoriasis drug shows promise in early trial
Disease control
Not yet recruiting
This study tests an experimental drug called D-2570 in 75 people with moderate to severe plaque psoriasis. Participants will receive either the drug or a placebo to see if it safely improves skin symptoms. The main goal is to measure how many achieve at least 90% clearer skin aft…
Phase: PHASE2 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated May 01, 2026 15:58 UTC